Abstract:Background Chronic hepatitis B is a primary cause of liver-related death. Interferon alpha (IFN-α) is able to inhibit the replication of hepadnavirus, and the sustained and stable expression of IFN-α at appropriate level may be beneficial to HBV clearance. With the development of molecular cloning technology, gene therapy plays a more and more important role in clinical practice. In light of the findings, an attempt to investigate the anti-HBV effects mediated by a eukaryotic expression plasmid (pSecTagB-IFN-α) in vitro was carried out. Methods HBV positive cell line HepG2.2.15 and its parental cell HepG2 were transfected with pSecTagB-IFN-α or empty plasmid by using Lipofectamine™ 2000 reagent. The expression levels of IFN-α were determined by reverse transcriptase polymerase chain reaction (RT-PCR) and ELISA methods. The effects of pSecTagB-IFN-α on HBV mRNA, DNA and antigens were analyzed by real-time fluorescence quantitative PCR (qRT-PCR) and ELISA assays. RT-PCR, qRT-PCR and western blot were employed to investigate the influence of pSecTagB-IFN-α on IFN-α-induced signal pathway. Furthermore, through qRT-PCR and ELISA assays, the suppressive effects of endogenously expressed IFN-α and the combination with lamivudine on HBV were also examined. Results pSecTagB-IFN-α could express efficiently in hepatoma cells, and then inhibited HBV replication, characterized by the decrease of HBV S gene (HBs) and HBV C gene (HBc) mRNA, the reduction of HBV DNA load, and the low contents of hepatitis B surface antigen (HBsAg) and hepatitis B e antigen (HBeAg). Mechanism research showed that the activation of Janus kinase (JAK)-signal transducer and activator of transcription (STAT) signal pathway, the up-regulation of IFN-α-induced antiviral effectors and double-stranded (ds) RNA sensing receptors by delivering pSecTagB-IFN-α, could be responsible for these phenomena. Furthermore, pSecTagB-IFN-α vector revealed effectively anti-HBV effect than exogenously added IFN-α. Moreover, lamivudine combined with endogenously expressed IFN-α exhibited stronger anti-HBV effect than with exogenous IFN-α. Conclusion Our results showed that endogenously expressed IFN-α can effectively and persistently inhibit HBV replication in HBV infected cells. These observations opened a promising way to design new antiviral genetic engineering drugs based on IFN-α.

[Human Interleukin-2 Gene Transfer and Expression Inhibits Hepatitis B Virus Surface Antigen Expression and Enhances LAK Activity of Peripheral Blood Mononuclear Cells of Normal Adults].

Immune Adjuvant Effect of Eukaryotic Expression Vector with Interleukin-2 on Hepatitis B Gene Vaccine

INTERLEUKIN-33 INHIBITS HEPATITIS B VIRUS REPLICATION IN THE LIVERS OF TRANSGENIC MICE

Effects on proliferativb activity of IL-2 gene modified K562 cells by retroviral mediated gene transfer

Transfer and Expression of Human Interferon- Α Gene and Its Effect on HBV Inhibition

The Targeted Expression of Interleukin-2 in Human Hepatocellular Carcinoma Cells

Potent Gene Transfer in Human Primary T Lymphocytes Using Interleukin-2-displaying Lentiviral Vectors

THE INFLUENCE OF HUMAN SINGLE CHAIN INTELEUKIN-12 GENE TRANSDUCTION ON THE BIOLOGICAL BEHAVIOR OF HEPATOMA 7721 CELLS

Inhibition of Hepatitis B Virus Gene Expression by Single and Dual Small Interfering RNA Treatment

Minicircle DNA vector expressing interferon-lambda-3 inhibits hepatitis B virus replication and expression in hepatocyte-derived cell line

Antitumor effect of gene therapy with recombinant adenovirus-mediated human interleukin-2 gene transfer and its mechanism]

Interleukin 12 affects immunization of hepatitis B DNA vaccine in mice

Interleukin-2 and Interferon-Fusion Protein Expression Plasmid Enhanced Potency of HBV DNA Vaccination in HBV Transgenic Mice

The Targeted Expression of Human IL 2/ifnα2b Fused Gene in Hepatoma Cells

The Anti-Hbv Effect Mediated by a Novel Recombinant Eukaryotic Expression Vector for IFN-α

Characterization of IL-21-expressing recombinant hepatitis B virus (HBV) as a therapeutic agent targeting persisting HBV infection

The Targeted Expression of the Human Interleukin-2/Interferon Α2b Fused Gene in Α-Fetoprotein-expressing Hepatocellular Carcinoma Cells

Transfusion of autologous cytokine-induced killer cells inhibits viral replication in patients with chronic hepatitis B virus infection.

Effect of Interlukin-2 Gene Transfection on Target Cells Membrane Function

622 ENHANCING ANTI-HEPATITIS B VIRUS MEDIATED IMMUNE RESPONSE BY NUCLEOS(T)IDE ANALOGS AND THYMOSIN-ALPHA1 THERAPY

Intracellular Application of Two-Unit Ribozyme Gene Against Hepatitis B Virus